With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
Women emerge as the cornerstone of this monumental undertaking
The company will provide comprehensive response to USFDA for the observations
The investment will catalyse various components of the IndiaAI Mission
The validations confirm the completion of the applications and commence the scientific review process
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Subscribe To Our Newsletter & Stay Updated
